{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:14:39Z","timestamp":1793326479217,"version":"4.5.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020320","name":"Institut pour la Recherche en Sant\u00e9 Publique","doi-asserted-by":"publisher","award":["IRESP-19-ADDICTIONS-16"],"award-info":[{"award-number":["IRESP-19-ADDICTIONS-16"]}],"id":[{"id":"10.13039\/501100020320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Therapeutic Communities (TCs) are long-term residential treatment settings for individuals with substance use disorders, who often present with neuropsychological impairments. These impairments may influence treatment retention, yet little is known about their evolution in TCs or their association with dropout. This study aims to: (1) identify early risk factors for dropout; (2) investigate the potential recovery from the risk of neuropsychological impairment during an 8-mont stay in a TC; and 3) identify variables at TC entry that may predict the risk of neuropsychological impairment during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fifty-seven residents from 3 French TCs completed clinical, substance use, and medical assessments, along with a neuropsychological screening (BEARNI) at entry. Twenty-four completed the 8-month follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The dropout rate was 47%. The only significant predictor of dropout was the BEARNI total score, with residents at lower risk of neuropsychological impairment more likely to leave the TC prematurely. Among completers, BEARNI total scores improved at follow-up, primarily explained by improvements in balance rather than in cognitive areas. Lower education, unemployment, recent alcohol use, depressive symptoms, and a history of hepatic disease were consistently associated with a higher risk of neuropsychological impairment at both time points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Unlike other treatment settings, the TC care framework may be particularly appropriate and supportive for residents who are more cognitively vulnerable, as they may be better able to benefit from TCs. Motor recovery among those who remain in treatment is encouraging. However, demographic, addiction-related, and comorbidity factors are consistently associated with the risk of neuropsychological impairment, both at baseline and after 8 months, suggesting a stable and persistent influence over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-07995-1","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:15:45Z","timestamp":1774062945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of neuropsychological impairment among therapeutic community residents: relationship with dropout and spontaneous recovery during treatment"],"prefix":"10.1186","volume":"26","author":[{"given":"Simon","family":"Deniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Delarue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Qu\u00e9telard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eflys","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Loz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Rimbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Longbottom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Kenens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bourguignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Rayneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Gaubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Beaunieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0320-8328","authenticated-orcid":false,"given":"Ludivine","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"7995_CR1","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3389\/fpsyt.2020.00786","volume":"11","author":"G De Leon","year":"2020","unstructured":"De Leon G, Unterrainer HF. The therapeutic community: a unique social psychological Approach to the Treatment of addictions and related disorders. Front Psychiatry. 2020;11:786.","journal-title":"Front Psychiatry"},{"key":"7995_CR2","unstructured":"F\u00e9d\u00e9ration Addiction. Annuaire national des structures de soin r\u00e9sidentiel en addictologie. 2024."},{"key":"7995_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugalcdep.2015.01.013","volume":"149","author":"D Fern\u00e1ndez-Calder\u00f3n","year":"2015","unstructured":"Fern\u00e1ndez-Calder\u00f3n D, Fern\u00e1ndez F, Ruiz-Curado S, Verdejo-Garc\u00eda A, Lozano \u00d3M. Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics. Drug Alcohol Depend. 2015;149:31\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"7995_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.drugalcdep.2017.04.023","volume":"178","author":"EM Marceau","year":"2017","unstructured":"Marceau EM, Berry J, Lunn J, Kelly PJ, Solowij N. Cognitive remediation improves executive functions, self-regulation and quality of life in residents of a substance use disorder therapeutic community. Drug Alcohol Depend. 2017;178:150\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"7995_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-022-01002-w","author":"C Tisdale","year":"2023","unstructured":"Tisdale C, Leung J, de Andrade D, Hides L. What Client Demographic, Substance Use, Mental Health, Treatment, and Psychological Variables Predict Residential Treatment Completion for Substance Use Disorders? Int J Ment Health Addict. 2023. https:\/\/doi.org\/10.1007\/s11469-022-01002-w.","journal-title":"Int J Ment Health Addict"},{"issue":"1","key":"7995_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2005.10.010","volume":"83","author":"PS Meier","year":"2006","unstructured":"Meier PS, Donmall MC, McElduff P, Barrowclough C, Heller RF. The role of the early therapeutic alliance in predicting drug treatment dropout. Drug Alcohol Depend. 2006;83(1):57\u201364.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"7995_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nrd3628","volume":"11","author":"MJ Millan","year":"2012","unstructured":"Millan MJ, Agid Y, Br\u00fcne M, Bullmore ET, Carter CS, Clayton NS, et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov. 2012;11(2):141\u201368.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"7995_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.neubiorev.2010.04.008","volume":"35","author":"MJ Fern\u00e1ndez-Serrano","year":"2011","unstructured":"Fern\u00e1ndez-Serrano MJ, P\u00e9rez-Garc\u00eda M, Verdejo-Garc\u00eda A. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci Biobehav Rev janv. 2011;35(3):377\u2013406.","journal-title":"Neurosci Biobehav Rev janv"},{"issue":"1","key":"7995_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/00952998409002657","volume":"10","author":"AT McLellan","year":"1984","unstructured":"McLellan AT, Childress AR, Griffith J, Woody GE. The psychiatrically severe drug abuse patient: methadone maintenance or therapeutic community? Am J Drug Alcohol Abuse. 1984;10(1):77\u201395.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"7995_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/10826084.2018.1517800","volume":"54","author":"D Shlosberg","year":"2019","unstructured":"Shlosberg D, Amit BH, Zalsman G, Krivoy A, Mell H, Lev-Ran S, et al. Cognitive Impairments in Abstinent Male Residents of a Therapeutic Community for Substance-Use Disorders: A Five-Year Retrospective Study. Subst Use Misuse. 2019;54(4):538\u201348.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"7995_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1468-2397.2008.00584.x","volume":"17","author":"JJ L\u00f3pez-Go\u00f1i","year":"2008","unstructured":"L\u00f3pez-Go\u00f1i JJ, Fern\u00e1ndez-Montalvo J, Illescas C, Landa N, Lorea I. Determining socio-demographic predictors of treatment dropout: Results in a therapeutic community. Int J Soc Welf. 2008;17(4):374\u20138.","journal-title":"Int J Soc Welf"},{"issue":"3","key":"7995_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1108\/TC-09-2015-0022","volume":"37","author":"B Turner","year":"2016","unstructured":"Turner B, Deane FP. Length of stay as a predictor of reliable change in psychological recovery and well being following residential substance abuse treatment. Ther Communities Int J Ther Communities. 2016;37(3):112\u201320.","journal-title":"Ther Communities Int J Ther Communities"},{"key":"7995_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jsat.2016.03.002","volume":"66","author":"EM Marceau","year":"2016","unstructured":"Marceau EM, Lunn J, Berry J, Kelly PJ, Solowij N. The Montreal Cognitive Assessment (MoCA) is Sensitive to Head Injury and Cognitive Impairment in a Residential Alcohol and Other Drug Therapeutic Community. J Subst Abuse Treat. 2016;66:30\u20136.","journal-title":"J Subst Abuse Treat"},{"key":"7995_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1037\/0893-164X.8.3.179","volume":"8","author":"W Fals-Stewart","year":"1994","unstructured":"Fals-Stewart W, Lucente S. Effect of neurocognitive status and personality functioning on length of stay in residential substance abuse treatment: An integrative study. Psychol Addict Behav. 1994;8:179\u201390.","journal-title":"Psychol Addict Behav"},{"issue":"3","key":"7995_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/00952990.2012.670866","volume":"38","author":"ML Copersino","year":"2012","unstructured":"Copersino ML, Schretlen DJ, Fitzmaurice GM, Lukas SE, Faberman J, Sokoloff J, et al. Effects of Cognitive Impairment on Substance Abuse Treatment Attendance: Predictive Validation of a Brief Cognitive Screening Measure. Am J Drug Alcohol Abuse mai. 2012;38(3):246\u201350.","journal-title":"Am J Drug Alcohol Abuse mai"},{"issue":"1","key":"7995_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejphar.2009.10.019","volume":"626","author":"MJ Fern\u00e1ndez-Serrano","year":"2010","unstructured":"Fern\u00e1ndez-Serrano MJ, P\u00e9rez-Garc\u00eda M, Perales JC, Verdejo-Garc\u00eda A. Prevalence of executive dysfunction in cocaine, heroin and alcohol users enrolled in therapeutic communities. Eur J Pharmacol. 2010;626(1):104\u201312.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"7995_CR17","first-page":"245","volume":"19","author":"KL Medina","year":"2004","unstructured":"Medina KL, Shear PK, Schafer J, Armstrong TG, Dyer P. Cognitive functioning and length of abstinence in polysubstance dependent men. Arch Clin Neuropsychol Off J Natl Acad Neuropsychol. 2004;19(2):245\u201358.","journal-title":"Arch Clin Neuropsychol Off J Natl Acad Neuropsychol"},{"issue":"1","key":"7995_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addbeh.2004.04.015","volume":"30","author":"AJ Verdejo-Garcia","year":"2005","unstructured":"Verdejo-Garcia AJ, L\u00f3pez-Torrecillas F, Aguilar de Arcos F, P\u00e9rez-Garc\u00eda M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict Behav. 2005;30(1):89\u2013101.","journal-title":"Addict Behav"},{"issue":"4","key":"7995_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00213-006-0632-8","volume":"190","author":"A Verdejo-Garc\u00eda","year":"2007","unstructured":"Verdejo-Garc\u00eda A, P\u00e9rez-Garc\u00eda M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology. 2007;190(4):517\u201330.","journal-title":"Psychopharmacology"},{"issue":"1","key":"7995_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/13803395.2016.1196165","volume":"39","author":"TP Schmidt","year":"2017","unstructured":"Schmidt TP, Pennington DL, Cardoos SL, Durazzo TC, Meyerhoff DJ. Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence. J Clin Exp Neuropsychol. 2017;39(1):22\u201334.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"7995_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cpr.2005.11.005","volume":"26","author":"CM Bradizza","year":"2006","unstructured":"Bradizza CM, Stasiewicz PR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin Psychol Rev. 2006;26(2):162\u201378.","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"7995_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/1533256X.2016.1200055","volume":"16","author":"KS Perkins","year":"2016","unstructured":"Perkins KS, Tharp BE, Ramsey AT. Patterson Silver Wolf (Adelv Unegv Waya) D. Mapping the Evidence to Improve Retention Rates in Addiction Services. J Soc Work Pract Addict. 2016;16(3):233\u201351.","journal-title":"J Soc Work Pract Addict"},{"issue":"8","key":"7995_CR23","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","volume":"33","author":"HH Brorson","year":"2013","unstructured":"Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: A systematic review of risk factors. Clin Psychol Rev. 2013;33(8):1010\u201324.","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"7995_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/1097-4679(199207)48:4<539::AID-JCLP2270480416>3.0.CO;2-I","volume":"48","author":"W Fals-Stewart","year":"1992","unstructured":"Fals-Stewart W, Schafer J. The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning. J Clin Psychol. 1992;48(4):539\u201343.","journal-title":"J Clin Psychol"},{"key":"7995_CR25","doi-asserted-by":"publisher","first-page":"117822181876055","DOI":"10.1177\/1178221818760551","volume":"12","author":"HW Andersson","year":"2018","unstructured":"Andersson HW, Steinsbekk A, Walderhaug E, Otterholt E, Nordfj\u00e6rn T. Predictors of Dropout From Inpatient Substance Use Treatment: A Prospective Cohort Study. Subst Abuse Res Treat. 2018;12:1178221818760551.","journal-title":"Subst Abuse Res Treat"},{"issue":"2","key":"7995_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/add.14793","volume":"115","author":"SN Lappan","year":"2020","unstructured":"Lappan SN, Brown AW, Hendricks PS. Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis. Addict Abingdon Engl. 2020;115(2):201\u201317.","journal-title":"Addict Abingdon Engl"},{"issue":"1","key":"7995_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000331007","volume":"18","author":"M Malivert","year":"2012","unstructured":"Malivert M, Fats\u00e9as M, Denis C, Langlois E, Auriacombe M. Effectiveness of therapeutic communities: a systematic review. Eur Addict Res. 2012;18(1):1\u201311.","journal-title":"Eur Addict Res"},{"issue":"3","key":"7995_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1037\/1064-1297.5.3.269","volume":"5","author":"W Fals-Stewart","year":"1997","unstructured":"Fals-Stewart W. Detection of neuropsychological impairment among substance-abusing patients: Accuracy of the Neurobehavioral Cognitive Status Examination. Exp Clin Psychopharmacol Exp Clin Psychopharmacol. 1997;5(3):269.","journal-title":"Exp Clin Psychopharmacol Exp Clin Psychopharmacol"},{"issue":"1","key":"7995_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/alcalc\/agac048","volume":"58","author":"B Angerville","year":"2023","unstructured":"Angerville B, Ritz L, Pitel AL, Beaunieux H, Houchi H, Martinetti MP, et al. Early Improvement of Neuropsychological Impairments During Detoxification in Patients with Alcohol Use Disorder. Alcohol Alcohol. 2023;58(1):46\u201353.","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"7995_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/01.ALC.0000156131.88125.2A","volume":"29","author":"ME Bates","year":"2005","unstructured":"Bates ME, Voelbel GT, Buckman JF, Labouvie EW, Barry D. Short-Term Neuropsychological Recovery in Clients with Substance Use Disorders. Alcohol Clin Exp Res. 2005;29(3):367\u201377.","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"7995_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cpr.2014.08.002","volume":"34","author":"MHJ Schulte","year":"2014","unstructured":"Schulte MHJ, Cousijn J, den Uyl TE, Goudriaan AE, van den Brink W, Veltman DJ, et al. Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. Clin Psychol Rev. 2014;34(7):531\u201350.","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"7995_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/01.ALC.0000156131.88125.2A","volume":"29","author":"ME Bates","year":"2005","unstructured":"Bates ME, Voelbel GT, Buckman JF, Labouvie EW, Barry D. Short-term neuropsychological recovery in clients with substance use disorders. Alcohol Clin Exp Res. 2005;29(3):367\u201377.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"7995_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/13803395.2016.1196165","volume":"39","author":"TP Schmidt","year":"2017","unstructured":"Schmidt TP, Pennington DL, Cardoos SL, Durazzo TC, Meyerhoff DJ. Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence. J Clin Exp Neuropsychol. 2017;39(1):22\u201334.","journal-title":"J Clin Exp Neuropsychol"},{"issue":"3","key":"7995_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/npp.2010.189","volume":"36","author":"AL Pitel","year":"2011","unstructured":"Pitel AL, Zahr NM, Jackson K, Sassoon SA, Rosenbloom MJ, Pfefferbaum A, et al. Signs of Preclinical Wernicke\u2019s Encephalopathy and Thiamine Levels as Predictors of Neuropsychological Deficits in Alcoholism without Korsakoff\u2019s Syndrome. Neuropsychopharmacology. 2011;36(3):580\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"7995_CR35","unstructured":"Deniel S, Delarue M, Qu\u00e9telard L, Miquel M, Loz\u00e9 S, Dumont M, et al. Risk of neuropsychological impairment in Therapeutic communities\u2019 residents at entry: which profile should alert us? https:\/\/hal.science\/hal-04037341"},{"key":"7995_CR36","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1037\/amp0000102","volume":"71","author":"American Psychological Association","year":"2016","unstructured":"American Psychological Association. Revision of Ethical Standard 3.04 of the Ethical Principles of Psychologists and Code of Conduct (2002, as amended 2010). Am Psychol. 2016;71:900\u2013900.","journal-title":"Am Psychol"},{"issue":"1","key":"7995_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1530-0277.1988.tb00137.x","volume":"12","author":"A Pfefferbaum","year":"1988","unstructured":"Pfefferbaum A, Rosenbloom M, Crusan K, Jernigan TL. Brain CT changes in alcoholics: effects of age and alcohol consumption. Alcohol Clin Exp Res. 1988;12(1):81\u20137.","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"7995_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"7995_CR39","unstructured":"Guelfi JD, Pichot P. L\u2019\u00e9valuation clinique standardis\u00e9e en psychiatrie. Boulogne; Paris: Editions m\u00e9dicales Pierre Fabre. 1996;2(783)."},{"issue":"11","key":"7995_CR40","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/acer.12888","volume":"39","author":"L Ritz","year":"2015","unstructured":"Ritz L, Lannuzel C, Boudehent C, Vabret F, Bordas N, Segobin S, et al. Validation of a brief screening tool for alcohol-related neuropsychological impairments. Alcohol Clin Exp Res. 2015;39(11):2249\u201360.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"7995_CR41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/10826084.2018.1517800","volume":"54","author":"D Shlosberg","year":"2019","unstructured":"Shlosberg D, Amit BH, Zalsman G, Krivoy A, Mell H, Lev-Ran S, et al. Cognitive Impairments in Abstinent Male Residents of a Therapeutic Community for Substance-Use Disorders: A Five-Year Retrospective Study. Subst Use Misuse. 2019;54(4):538\u201348.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"7995_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11065-007-9037-7","volume":"17","author":"JP Caplan","year":"2007","unstructured":"Caplan JP, Epstein LA, Quinn DK, Stevens JR, Stern TA. Neuropsychiatric effects of prescription drug abuse. Neuropsychol Rev. 2007;17(3):363\u201380.","journal-title":"Neuropsychol Rev"},{"issue":"3","key":"7995_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11065-007-9036-8","volume":"17","author":"R Gonzalez","year":"2007","unstructured":"Gonzalez R. Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev. 2007;17(3):347\u201361.","journal-title":"Neuropsychol Rev"},{"issue":"2","key":"7995_CR44","first-page":"125","volume":"27","author":"M Oscar-Berman","year":"2003","unstructured":"Oscar-Berman M, Marinkovic K. others. Alcoholism and the brain: an overview. Alcohol Res Health. 2003;27(2):125\u201333.","journal-title":"Alcohol Res Health"},{"issue":"3","key":"7995_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","volume":"17","author":"JC Scott","year":"2007","unstructured":"Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, et al. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev. 2007;17(3):275\u201397.","journal-title":"Neuropsychol Rev"},{"key":"7995_CR46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1468-2397.2008.00584.x","volume":"17","author":"JJ L\u00f3pez-Go\u00f1i","year":"2008","unstructured":"L\u00f3pez-Go\u00f1i JJ, Fern\u00e1ndez-Montalvo J, Illescas C, Landa N, Lorea I. Determining socio-demographic predictors of treatment dropout: Results in a therapeutic community. Int J Soc Welf. 2008;17:374\u20138.","journal-title":"Int J Soc Welf"},{"issue":"3","key":"7995_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.drugalcdep.2005.08.003","volume":"81","author":"E Aharonovich","year":"2006","unstructured":"Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend. 2006;81(3):313\u201322.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"7995_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/1097-4679(199207)48:4<539::AID-JCLP2270480416>3.0.CO;2-I","volume":"48","author":"W Fals-Stewart","year":"1992","unstructured":"Fals-Stewart W, Schafer J. The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning. J Clin Psychol. 1992;48(4):539\u201343.","journal-title":"J Clin Psychol"},{"issue":"5","key":"7995_CR49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.32598\/bcn.2021.809.3","volume":"12","author":"T Rezapour","year":"2021","unstructured":"Rezapour T, Barzegari M, Sharifi E, Malmir N, Ghiasvand H, Salehi M, et al. Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders. Basic Clin Neurosci. 2021;12(5):597\u2013606.","journal-title":"Basic Clin Neurosci"},{"issue":"1","key":"7995_CR50","doi-asserted-by":"publisher","first-page":"e0296043","DOI":"10.1371\/journal.pone.0296043","volume":"19","author":"A Powell","year":"2024","unstructured":"Powell A, Sumnall H, Smith J, Kuiper R, Montgomery C. Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Systematic review of longitudinal studies. PLoS ONE. 2024;19(1):e0296043.","journal-title":"PLoS ONE"},{"issue":"8","key":"7995_CR51","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","volume":"33","author":"HH Brorson","year":"2013","unstructured":"Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 2013;33(8):1010\u201324.","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"7995_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1176\/appi.ps.201300242","volume":"65","author":"S Reif","year":"2014","unstructured":"Reif S, George P, Braude L, Dougherty RH, Daniels AS, Ghose SS, et al. Residential Treatment for Individuals With Substance Use Disorders: Assessing the Evidence. Psychiatr Serv. 2014;65(3):301\u201312.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"7995_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/07347324.2013.831688","volume":"32","author":"TK Hill","year":"2014","unstructured":"Hill TK, Colistra AL. Addiction-Related Cognitive Impairment in Substance Use Disorder Treatment: Behavioral Suggestions for Addictions Treatment Practitioners. Alcohol Treat Q. 2014;32(1):19\u201332.","journal-title":"Alcohol Treat Q"},{"issue":"3\u20134","key":"7995_CR54","first-page":"103","volume":"17","author":"B Loyer","year":"2011","unstructured":"Loyer B. Fen\u00eatres ouvertes sur la clinique. Open windows on the clinical work. Psychotropes. 2011;17(3\u20134):103\u201316.","journal-title":"Psychotropes"},{"key":"7995_CR55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jsat.2017.01.016","volume":"76","author":"E Hagen","year":"2017","unstructured":"Hagen E, Erga AH, Hagen KP, Nesv\u00e5g SM, McKay JR, Lundervold AJ, et al. One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder. J Subst Abuse Treat. 2017;76:81\u20137.","journal-title":"J Subst Abuse Treat"},{"key":"7995_CR56","doi-asserted-by":"publisher","first-page":"106350","DOI":"10.1016\/j.addbeh.2020.106350","volume":"105","author":"A Maillard","year":"2020","unstructured":"Maillard A, Poussier H, Boudehent C, Lannuzel C, Vicente A, Vabret F, et al. Short-term neuropsychological recovery in alcohol use disorder: A retrospective clinical study. Addict Behav. 2020;105:106350.","journal-title":"Addict Behav"},{"issue":"1","key":"7995_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/alcalc\/agac048","volume":"58","author":"B Angerville","year":"2023","unstructured":"Angerville B, Ritz L, Pitel AL, Beaunieux H, Houchi H, Martinetti MP, et al. Early Improvement of Neuropsychological Impairments During Detoxification in Patients with Alcohol Use Disorder. Alcohol Alcohol Oxf Oxfs. 2023;58(1):46\u201353.","journal-title":"Alcohol Alcohol Oxf Oxfs"},{"issue":"2","key":"7995_CR58","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0887-6177(03)00043-X","volume":"19","author":"KL Medina","year":"2004","unstructured":"Medina KL, Shear PK, Schafer J, Armstrong TG, Dyer P. Cognitive functioning and length of abstinence in polysubstance dependent men. Arch Clin Neuropsychol. 2004;19(2):245\u201358.","journal-title":"Arch Clin Neuropsychol"},{"issue":"3","key":"7995_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/1467-9280.00130","volume":"10","author":"S Jo Nixon","year":"1999","unstructured":"Jo Nixon S. Neurocognitive performance in alcoholics: Is polysubstance abuse important? Psychol Sci. 1999;10(3):181\u20135.","journal-title":"Psychol Sci"},{"key":"7995_CR60","doi-asserted-by":"crossref","unstructured":"Fein G, Greenstein D. Gait and Balance Deficits in Chronic Alcoholics: No Improvement from 10 Weeks Through 1 Year Abstinence. Alcohol Clin Exp Res; 2012.","DOI":"10.1111\/j.1530-0277.2012.01851.x"},{"issue":"12","key":"7995_CR61","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1111\/j.1530-0277.2011.01567.x","volume":"35","author":"S Smith","year":"2011","unstructured":"Smith S, Fein G. Persistent but Less Severe Ataxia in Long-Term Versus Short-Term Abstinent Alcoholic Men and Women: A Cross-Sectional Analysis. Alcohol Clin Exp Res. 2011;35(12):2184\u201392.","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"7995_CR62","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1064-1297.10.3.193","volume":"10","author":"ME Bates","year":"2002","unstructured":"Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol ao\u00fbt. 2002;10(3):193\u2013212.","journal-title":"Exp Clin Psychopharmacol ao\u00fbt"},{"key":"7995_CR63","doi-asserted-by":"publisher","first-page":"108132","DOI":"10.1016\/j.addbeh.2024.108132","volume":"158","author":"MA Gautron","year":"2024","unstructured":"Gautron MA, Clergue-Duval V, Chantre J, Lejoyeux M, Geoffroy PA. Predictive factors of cognitive impairment in alcohol use disorder inpatients. Addict Behav. 2024;158:108132.","journal-title":"Addict Behav"},{"issue":"4","key":"7995_CR64","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/01.ALC.0000122761.09179.B9","volume":"28","author":"M Oscar-Berman","year":"2004","unstructured":"Oscar-Berman M, Kirkley SM, Gansler DA, Couture A. Comparisons of Korsakoff and Non-Korsakoff Alcoholics on Neuropsychological Tests of Prefrontal Brain Functioning. Alcohol Clin Exp Res avr. 2004;28(4):667\u201375.","journal-title":"Alcohol Clin Exp Res avr"},{"issue":"9","key":"7995_CR65","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/archpsyc.1978.01770330037003","volume":"35","author":"I Grant","year":"1978","unstructured":"Grant I, Adams KM, Carlin AS, Rennick PM, Judd LL, Schooff K. The collaborative neuropsychological study of polydrug users. Arch Gen Psychiatry. 1978;35(9):1063\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"7995_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000525988","volume":"28","author":"SPG Zetsen","year":"2022","unstructured":"Zetsen SPG, Schellekens AFA, Paling EP, Kan CC, Kessels RPC. Cognitive Functioning in Long-Term Benzodiazepine Users. Eur Addict Res. 2022;28(5):377\u201381.","journal-title":"Eur Addict Res"},{"key":"7995_CR67","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.alcohol.2019.12.003","volume":"85","author":"TC Durazzo","year":"2020","unstructured":"Durazzo TC, Meyerhoff DJ. Cigarette smoking history is associated with poorer recovery in multiple neurocognitive domains following treatment for an alcohol use disorder. Alcohol Fayettev N. 2020;85:135\u201343.","journal-title":"Alcohol Fayettev N"},{"issue":"11","key":"7995_CR68","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1046\/j.1360-0443.2003.00526.x","volume":"98","author":"J Uekermann","year":"2003","unstructured":"Uekermann J, Daum I, Schlebusch P, Wiebel B, Trenckmann U. Depression and cognitive functioning in alcoholism. Addiction. 2003;98(11):1521\u20139.","journal-title":"Addiction"},{"issue":"10","key":"7995_CR69","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.addbeh.2009.03.036","volume":"34","author":"SA Hunt","year":"2009","unstructured":"Hunt SA, Baker AL, Michie PT, Kavanagh DJ. Neurocognitive profiles of people with comorbid depression and alcohol use: implications for psychological interventions. Addict Behav. 2009;34(10):878\u201386.","journal-title":"Addict Behav"},{"issue":"5","key":"7995_CR70","first-page":"887","volume":"10","author":"B Luque","year":"2022","unstructured":"Luque B, Garc\u00eda V, Tabernero C. Depression and Cognitive Impairment in a Spanish Sample of Psychoactive Substance Users Receiving Mental Health Care. Healthc Basel Switz. 2022;10(5):887.","journal-title":"Healthc Basel Switz"},{"key":"7995_CR71","doi-asserted-by":"publisher","first-page":"111085","DOI":"10.1016\/j.pnpbp.2024.111085","volume":"134","author":"JE Marquez-Arrico","year":"2024","unstructured":"Marquez-Arrico JE, Catal\u00e1n-Aguilar J, Navarro JF, Adan A. Neurocognitive and clinical profile of male patients with substance use disorder in early remission phase with and without comorbid depression. Prog Neuropsychopharmacol Biol Psychiatry. 2024;134:111085.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1\u20132","key":"7995_CR72","first-page":"87","volume":"33","author":"G Szabo","year":"2010","unstructured":"Szabo G, Mandrekar P. Focus On: Alcohol and the Liver. Alcohol Res Health. 2010;33(1\u20132):87\u201396.","journal-title":"Alcohol Res Health"},{"issue":"3","key":"7995_CR73","first-page":"e23630","volume":"14","author":"T Dolkar","year":"2022","unstructured":"Dolkar T, Hamad AM, Han MM, Thu MB, Gayam VR. Cocaine and Opioid-Induced Acute Liver Injury: A Rare Case Report. Cureus mars. 2022;14(3):e23630.","journal-title":"Cureus mars"},{"key":"7995_CR74","doi-asserted-by":"publisher","first-page":"108531","DOI":"10.1016\/j.drugalcdep.2021.108531","volume":"220","author":"MK Baum","year":"2021","unstructured":"Baum MK, Tamargo JA, Ehman RL, Sherman KE, Chen J, Liu Q, et al. Heroin use is associated with liver fibrosis in the Miami Adult Studies on HIV (MASH) cohort. Drug Alcohol Depend. 2021;220:108531.","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"7995_CR75","doi-asserted-by":"publisher","first-page":"e0159616","DOI":"10.1371\/journal.pone.0159616","volume":"11","author":"L Ritz","year":"2016","unstructured":"Ritz L, Coulbault L, Lannuzel C, Boudehent C, Segobin S, Eustache F, et al. Clinical and Biological Risk Factors for Neuropsychological Impairment in Alcohol Use Disorder. PLoS ONE. 2016;11(9):e0159616.","journal-title":"PLoS ONE"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07995-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07995-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07995-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:09:57Z","timestamp":1777435797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07995-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7995"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07995-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee (CLERS) of the University of Caen, under approval number 3627. All participants were informed about the study\u2019s purpose and data collection procedures prior to inclusion and provided their written informed consent. The Ethical Principles of Psychologists and Code of Conduct of the American Psychological Association [\n                      \n                      ] regarding the ethical treatment of human participants were respected for all participants. The study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}